Myxoid Liposarcoma — Trials

Myxoid Liposarcoma — Trials · CancerIndex

Clinical trials

Registered studies

31 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 42%
Top sponsor: USWM CT, LLC
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03397186	Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma	withdrawn	Phase 2	0	Fred Hutchinson Cancer CenterOTHER	1	Sep 10, 2019	clinicaltrials
NCT02059850	NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma	withdrawn	Phase 1	0	Fred Hutchinson Cancer CenterOTHER	1	Feb 3, 2016	clinicaltrials